drugset / Trial / NCT02042729
A Phase 1 Comparative Study of E2022 Current and New Patch Formulations
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and pharmacokinetics of new patch formulation (tape) of E2022 by conducting patch test.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-10
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | — | Topical |
Indications
No indication recorded.